Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Angle Plc LSE:AGL London Ordinary Share GB0034330679 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.70 -3.2% 81.80 81.00 82.60 84.50 79.50 84.50 600,346 13:44:37
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.6 -7.7 -3.8 - 176

Angle Share Discussion Threads

Showing 54576 to 54597 of 54600 messages
Chat Pages: 2184  2183  2182  2181  2180  2179  2178  2177  2176  2175  2174  2173  Older
DateSubjectAuthorDiscuss
27/2/2021
16:15
4D Pharma also merging with a Spac and listing on Nas after March 22.
eeza
26/2/2021
14:52
hTTps://t.me/joinchat/SsO9NhkrRKH9KPecTA4WCA
sicilian_kan
26/2/2021
13:46
As I have said before no one truly knows the likely FDA decision date so given the 150 days target is now past surely it is best to ensure your preferred stock holding position ( whether that is more or less than now) is in place rather than kicking yourself when the RNS pops up 7am one morning , albeit next Monday or June. I am interested to see the mix of poster comments on ‘D day’ .
millwallfan
26/2/2021
10:19
aye someone dm me a link too thanks.
tomphys
26/2/2021
10:18
Do you know if candlesticks data was for cases that had a Q submission?
bagpuss67
26/2/2021
10:15
Could someone please dm me a link to the Telegram group?
signals22
26/2/2021
09:53
Not known. Some will have been but I doubt many. I also think it fair to assume that now we are this far down the line in terms of the FDA submission that if there were some fundamental problem with the core data (e.g. requiring additional clinical trials to prove the device works because the core data was just not good enough) that this would have been raised by the FDA by now, the Q2 timeline would clearly be missed by a couple of years, and there would have been an RNS about it. That has not happened and we know the primary and secondary endpoints were met, so I at the moment am very comfortable holding.
sicilian_kan
26/2/2021
09:42
And l assume these applications didn't go through the Q submission initially SK? We know that this would be advantageous for Angle to do this.
maxie23
26/2/2021
09:33
Candlestick put some analysis on Telegram earlier this week. He looked at previous in vitro de novo applications and worked out the 20, 40, 60, 80 and 100 percentiles for length of time from application to decision granted. He then applied these to Angle, which show: 20th percentile - 18 Feb 2021 40th percentile - 10 Apr 2021 60th percentile - 26 Jul 2021 80th percentile - 25 Aug 2021 100th percentile - 4 Jul 2022 So the Streck timeline I put above appears to be around the average mark. This also tallies with Newland's estimate of Q2.
sicilian_kan
26/2/2021
09:32
Yes, I thought it unlikely that the application would sail straight through so, sensibly there has been some leeway provided for. Meanwhile AGL hasn’t been standing still - we await news on other stuff.
semper vigilans
26/2/2021
09:31
Apols. I had thought there had been some analysis on here or another BB that showed the FDA were still achieving their targets notwithstanding covid. But I will stand corrected as others are clearly better informed on the impact of CV on FDA approvals. Cheers
bagpuss67
26/2/2021
09:30
Q2, CY21 = 1 March 21 to 30 June 21 Edit Lol Went to write 31 March and 3 didn't appear. Should be 1 April start of Q" - Fools day.
eeza
26/2/2021
09:29
Streck, the only company with a liquid biopsy (ctDNA) connected de novo application that I have found, got their approval in 9 months from the FDA. If it takes the same amount of time for ANGLE, then we are looking at June. I add though that Streck had not as far as I am aware done a Q Submission previously, which should speed matters up.
sicilian_kan
26/2/2021
09:26
IMO there would have been numbers of data requests/queries made by the FDA regarding the DeNovo simply because the FDA have to cover all the bases on the technology. Every time a request was made the clock would have stopped even for a couple of days. AN said Q2 because there is no chance of Q1. Best to relax. Wait for the RNS. Load up IMO at the present prices. I am buying more Monday even though I bought more Monday this week when they are 89p....
purchaseatthetop
26/2/2021
09:24
@bagpuss, i think he is factoring in Covid mate. I think after the delays due to covid last year it is a great unknown so because of that he is managing expectations. Id also assume the FDA is very pre occupied with Covid related stuff. If it does take until June or later i see this dropping back a big before that which will just mean i buy a lot more shares. The extra wait is annoying but could benefit us
tomphys
26/2/2021
09:24
>> Bagpuss Apparently there has been a global pandemic - and this might possibly have affected the priorities inside the FDA.
toffeeman
26/2/2021
09:18
Hopefully no one is getting over excited. BUT Are we sure that ANs comments don't include some management of expectations. Is there a reason we know of why it woukd take at least a month longer than the target period for the FDA...
bagpuss67
26/2/2021
09:11
Angle have stated, more than once, that they never expected FDA clearance as soon as this month so you may well have to wait until June before you start to panic. From the interim results "earliest prospect of FDA clearance Q2 CY21" From the RNS on 20/10/20 "ANGLE believes that the earliest prospect of FDA clearance is Q2 CY21"
this_is_me
26/2/2021
07:09
Morning all. I think that is 150 days. No RNS yet saying major issue.
bagpuss67
24/2/2021
16:56
Exactly Waterloo, obviously to a lot it sounds like dreaming when we talk of 10 billion plus but outs. But there's a very strong possibility than even in 10 years time the likes of grail will still be selling glorified dna tests in the post, while parsortix will be being used everywhere. If it even looks like that might happen in the next year you can get the big companies will be swarming like sharks
tomphys
24/2/2021
15:47
IMHO the rise today is people getting their position ready as the FDA COULD be any time now. Hopefully we will now see slow upward drift as the clock ticks down
millwallfan
24/2/2021
14:04
tomphys, agree and Illumina recently paid $8bn for the bit they didn't own!
waterloo01
Chat Pages: 2184  2183  2182  2181  2180  2179  2178  2177  2176  2175  2174  2173  Older
ADVFN Advertorial
Your Recent History
LSE
AGL
Angle
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210227 22:13:42